You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma celebrates Primary Immunodeficiency Week

The company stands alongside PI patients associations around the globe

read more 

EVENTS

Kedrion Biopharma celebrates World Hemophilia Day 2018

Support for patients with coagulation disorders worldwide is confirmed

read more 

EVENTS

50-Year Anniversary of a Maternal Health Breakthrough

Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai

read more 
  1. EVENTS - 27-04-2017

    Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017

    Global campaign to improve early diagnosis and optimal treatments for PID

    read more 
  2. CORPORATE - 19-04-2017

    Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)

    The agreement aims to improve patient access to coagulation disorders treatments in Europe

    read more 
  3. EVENTS - 14-04-2017

    Kedrion Biopharma initiatives for World Hemophilia Day 2017

    The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over

    read more 
  4. CORPORATE - 24-03-2017

    New company AO Kirov Plasma established in Russia

    It’s a joint venture between Kedrion Biopharma, Nacimbio and Pharmastandard

    read more 

Pages

For more information please contact: pressoffice@kedrion.com